![Synthesis and evaluation of 11C-LY2795050 as a κ-opioid receptor antagonist radiotracer for PET imaging. - Abstract - Europe PMC Synthesis and evaluation of 11C-LY2795050 as a κ-opioid receptor antagonist radiotracer for PET imaging. - Abstract - Europe PMC](https://europepmc.org/articles/PMC3775344/bin/nihms483815f5.jpg)
Synthesis and evaluation of 11C-LY2795050 as a κ-opioid receptor antagonist radiotracer for PET imaging. - Abstract - Europe PMC
![Analysis of Ikaros-DNA interaction in PHA-activated EL-4 cells using in... | Download Scientific Diagram Analysis of Ikaros-DNA interaction in PHA-activated EL-4 cells using in... | Download Scientific Diagram](https://www.researchgate.net/publication/11537641/figure/fig5/AS:460121580019717@1486712941458/Analysis-of-Ikaros-DNA-interaction-in-PHA-activated-EL-4-cells-using-in-vivo-formaldehyde_Q640.jpg)
Analysis of Ikaros-DNA interaction in PHA-activated EL-4 cells using in... | Download Scientific Diagram
Claire Paul - Program Coordinator of Special Education - The University of Tennessee Southern | LinkedIn
![Synthesis and Evaluation of 11C-LY2795050 as a κ-Opioid Receptor Antagonist Radiotracer for PET Imaging | Journal of Nuclear Medicine Synthesis and Evaluation of 11C-LY2795050 as a κ-Opioid Receptor Antagonist Radiotracer for PET Imaging | Journal of Nuclear Medicine](https://jnm.snmjournals.org/sites/default/files/highwire/jnumed/54/3.cover-source.jpg)
Synthesis and Evaluation of 11C-LY2795050 as a κ-Opioid Receptor Antagonist Radiotracer for PET Imaging | Journal of Nuclear Medicine
![Preclinical Testing of Nalfurafine as an Opioid-sparing Adjuvant that Potentiates Analgesia by the Mu Opioid Receptor-targeting Agonist Morphine | Journal of Pharmacology and Experimental Therapeutics Preclinical Testing of Nalfurafine as an Opioid-sparing Adjuvant that Potentiates Analgesia by the Mu Opioid Receptor-targeting Agonist Morphine | Journal of Pharmacology and Experimental Therapeutics](https://jpet.aspetjournals.org/content/jpet/371/2/487/F1.large.jpg)
Preclinical Testing of Nalfurafine as an Opioid-sparing Adjuvant that Potentiates Analgesia by the Mu Opioid Receptor-targeting Agonist Morphine | Journal of Pharmacology and Experimental Therapeutics
![Strategies for Developing κ Opioid Receptor Agonists for the Treatment of Pain with Fewer Side Effects | Journal of Pharmacology and Experimental Therapeutics Strategies for Developing κ Opioid Receptor Agonists for the Treatment of Pain with Fewer Side Effects | Journal of Pharmacology and Experimental Therapeutics](https://jpet.aspetjournals.org/content/jpet/375/2/332/F2.large.jpg)